Amphastar Pharmaceuticals, Inc. — Director's Dealing 2018

Mar 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2018-03-15

Reporting Person: Shandell Jason B. (Director, President and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-15	Common Stock	A	39919	$0.00	Acquired	256867	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-15	Employee Stock Option (right to buy)	$19.79	A	92692	Acquired	2028-03-15	Common Stock (92692)	Direct

Footnotes

F1: The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 15, 2019.

F2: Shares subject to the option vest in four equal annual installments beginning on March 15, 2019.